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The synthesis of the potent and highly selective 
silicon-containing antimuscarinic agent o-methoxy-
sila-hexocyclium methyl sulfate and its correspon-
ding tertiary amine (isolated as the dihydrochloride) 
is described. The quarternary compound is an o-
methoxy derivative of sila-hexocyclium methyl 
sulfate, which represents one of the tools currently 
used in experimental pharmacology for the 
subclassification of muscarinic receptors. The o-
methoxy derivative, the pharmacological profile of 
which differs substantially from tbat of the non-
methoxy compound, is also recommended as a tool 
for the investigation of muscarinic receptor 
heterogeneity. 
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INTRODUCTION 
Recently, we reported on the synthesis of the selec-
tive antimuscarinic agent sila-hexocyclium methyl 
sulfate (lb, Scheme 1).' This silanol, a silicon 
analogue of the spasmolytic and anti-ulcer agent hexo-
cyclium methyl sulfate (la, Scheme 1), has become 
an important tool in experimental pharmacology for 
tTo whom correspondence should be addressed. 
the classification of subtypes of muscarinic recep-
tors. 2•3 lt shows approximately the samehigh affinity 
to muscarinic M 1 receptors in neuronal tissues and to 
M2ß receptors in smooth muscle organs and exocrine 
glands, whereas its antimuscarinic potency at cardiac 
M2a receptors is lower by more than one order of 
magnitude. 
The corresponding o-methoxy derivative, o-
methoxy-sila-hexocyclium methyl sulfate (4), was also 
found to be a potent and highly selective antimuscarinic 
agent. The pharmacological profile, however, differs 
substantially from that of sila-hexocyclium methyl 
sulfate (lb). 4 A 22-fold difference in the affinity was 
found for 4 on neuronal M 1 receptors compared with 
the affinity to M2ß receptors in smooth muscle. Ad-
ditionally, the affinity found for this agent on cardiac 
M2a receptors was lower than on M2ß receptors by 
a factor of 3 .5. Thus, the difference in affinity for o-
methoxy-sila-hexocyclium methyl sulfate (4) for MI 
over M2a receptors is 78-fold. To the best of our 
knowledge, silanol4 is the first quatemary amrnonium 
compound with high M 1 receptor selectivity. 
Here we report on the synthesis of o-methoxy-sila-
hexocyclium methyl sulfate (4). In addition, the syn-
thesis of its corresponding tertiary amine (isolated as 
the dihydrochloride 5) is described, the antimuscarinic 
properties of which are currently under investigation. 
This paper represents a further report on our systematic 
studies on sila-substituted drugs (for recent reviews on 
this subject, see Refs 5 and 6). 
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EXPERIMENTAL 
All synthetic procedures were performed under a 
nitrogen atmosphere andin dried solvents unless other-
wise stated. Melting points were determined using a 
Kofler apparatus and are reported without correction. 
1H and 13C NMR spectra were recorded on a Bruker 
WM -400 spectrometer operating at 400.1 and 
100.6 MHz, respectively. Chemical shifts (ppm) were 
measured with respect to those of (CH3)4Si ctH, ö = 
0) and CDC1 3 ( 13C, ö = 77.05) as internal 
references. Assignment of the 13C data was supported 
by DEPT (distortionless enhancement by polarization 
transfer) experiments. Mass spectra were obtained on 
a Finnigan-MA T -8430 mass spectrometer [EI MS: 70 
eV; FAB MS: glycerol (liquid matrix), xenon (FAB 
source)]. The m/z values given are related to the 
isotopes 1H, 12C, 14N, 160 and 28Si. 
1. H20 
2. HCl 
Cyclohexyldlmethoxy[(1·methylplperazln· 
4-yl)methyl]sllane (2) 
This compound (Scheme 2) was prepared according 
to Ref. I. 
Cyclohexylmethoxy(2·mathoxyphenyl)· 
[( 1-methylplperazln·4·yl)methyl]sllane (3) 
A solution of n-butyllithium (60 mmol) in n-hexane 
(37.5 cm3) was added dropwise at -30°C to a stirred 
solution of o-bromoanisole (11.2 g, 60 mmol) in 
diethyl ether (60 cm3). After stirring for 2 h at 
- 30°C, the reaction mixture was added dropwise 
within 20 min to a stirred solution of 2 (15.0 g, 
52.4 mmol) in diethyl ether (200 cm3) at 0°C. After 
stirring for 1 h at room temperature and heating at 
reflux for 3 h, the reaction mixture was cooled to room 
Scheme 2 
o-Methoxy-sila-hexocyclium methy I sulfate 
temperature. The insoluble material was fittered off 
and the filtratewas concentrated in vacuo. n-Hexane 
(200 cm3) was added to the residue and the precipitate 
formed was filtered off. After concentrating the filtrate 
under reduced pressure, the remaining oily residue was 
distilled in vacuo (short Vigreux column) to give 12.9 g 
(yield 68%) of a colourless liquid, b. p. 
164°C/0.005 Torr. 1H NMR (CDC13): o 1.0-1.3, 
1.55-1.75 (m, llH; SiC6H11), 2.20 (s, 3H; NCH3), 
2.25 and 2.34 (AB system, J AB = 14.8 Hz, 2H; 
SiCH2N), 2.15-2.6 (m, 8H; CCH2N), 3.60 (s, 3H; 
SiOCH3), 3.75 (s, 3H; COCH3), 6.75-7.55 (m, 4H; 
aryl H). 13C NMR (CDC13): o 25.8 (C-1, SiC6H11), 
26.8, 26.9 (2C), 27.9 and 28.0 (C-2-C-6, SiC6H11 ), 
45.9 (NCH3), 46.2 (SiCH2N), 51.6 (SiOCH3), 54.6 
(COCH3), 55.5 (2C) and 56.7 (2C) (CCH2N), 109.3 
(C-3~ aryl C), 120.4 (C-5, aryl C), 123.2 (C-1, aryl 
C), 131.0 (C-4, aryl C), 136.0 (C-6, aryl C), 163.8 
(C-2, aryl C). EI MS: m/z 362 (40%, M+), 113 
(100%, C6H13N2 +). Calcd. for C20H34N202Si: C, 
66.25; H, 9.45; N 7.73. Found: C, 66.1; H, 9.5; N, 
7.8%. 
4· ( [Cyclohexylhydroxy· 
(2-methoxyphenyl)sllyl]methyl } • 
1, 1-dlmethylplperazlnlum methyl sulfate 
(o·methoxy·slla·hexocycllum methyl 
sulfate) (4) 
Dirnethylsulfate (1.12 g, 8.88 mmol) was added drop-
wise at ooc to a stirred solution of 3 (3.25 g, 
8.96 mmol) in acetone (80 cm3). After stirring for 
12 h at 20°C, the solvent was removed in vacuo and 
diethyl ether (150 cm3) was added to the residue. The 
solid material formed was separated by filtration, wash-
ed with diethyl ether (80 cm3) and dried in vacuo at 
50°C. The solid was dissolved in water (120 cm3) and 
the resulting solutionwas stirred for 1 hat 50°C. After 
removing the water in vacuo, the solid residue was 
crystallized from acetone/diethyl ether (2: 1, v/v) to 
give 2.7 g (yield 64%) of colourless crystals, m.p. 
129°C. 1H NMR (CDC13): o 0.85-1.3, 1.5-1.8 (m, 
llH; SiC6Hu), 2.33 and 2.36 (AB system, ]AB = 
14.7 Hz, 2H; SiCH2N), 2.6-2.8 (m, 4H; CCH2N), 
3.21 (s, 6H; NCH3 , 3.35-3.5 (m, 4H; CCH2N+), 
3.64 (s, 3H; SOCH3), 3.80 (s, 3H; COCH3), 4.1 ('s', 
broad, 1H; SiOH), 6. 75-7.55 (m, 4H; aryl H). 13C 
NMR (CDC13): o 26.3 (C-1, SiC6Hn), 26.8 (3C), 
27.9 and 28.0 (C-2- C-6, SiC6H11 ), 46.3 (SiCH2N), 
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50.1 (2C) (CCH2N), 51.3 (2C) (NCH3), 54.4 and 
55.0 
(SOCHJ, COCH3), 62.0 (2C) (CCH2N+), 109.5 
(C-3, aryl C),-120.9 (C-5, aryl C), l23.9 (C-1, aryl 
C), 131.4 (C-4, aryl C), 135.8 (C-6, aryl C), 163.6 
(C-2, aryl C). FAB MS: mlz 363 (cation of 4). Ca1cd. 
for C21H3sN206SSi: C, 53.14; H, 8.07; N, 5.90. 
Pound: C, 53.0; H, 8.1; N, 5.8%. 
Cyclohexylmethoxy(2-methoxyphenyl)· 
[(1-methylplperazln-4-yl)methyl]sllanol 
dlhydrochlorlde (5) 
Water (1 cm3) was added to a solution of 3 (1.00 g, 
2. 76 mmol) in diethyl ether (70 cm3), and the 
resulting reaction mixturewas stirred for 1 hat 20°C. 
The organic layer was quickly separated, dried over 
anhydrous Na2S04 and cooled to 0°C. A 0.5 mol 
dm- 3 solution of hydrogen chloride in diethyl ether 
( 14 cm3) was added and the reaction mixture was stir-
red for 5 min. The resulting precipitate was collected 
by filtration and crystallized from acetonitrile to give 
0.9 g (yield 77%) of colourless crystals, m.p. 
194-197°C. 1H NMR (CDCI 3): o 0.9-1.1, 
1.1-1.4, 1.5-1.9 (m, 11H; SiC6H11), 2.87 (s, 3H; 
NCH3), 2.9-3.0 (m, 2H; SiCH2N), 3.15-4.0 (m, 
8H; CCH2N), 3.84 (s, 3H; OCH3), 5.4 ('s', broad, 
1H; SiOH), 6.85-7.65 (m, 4H; aryl H), 12.2 ('s', 
broad; NH), 13.4 ('s', broad; NH). 13C NMR 
(CDC13): o 25.7 (C-1, SiC6H11), 26.3, 26.4, 26.5, 
27.5 and 27.6 (C-2-C-6, SiC6H 11), 43.0 (NCH3), 
46.7 (SiCH2N), 50.2, 50.3 and 52.7 (2C) (CGI2N), 
55.3 (OCH3), 109.7 (C-3, aryl C), 121.0 (C-=1, aryl 
C), 121.6 (C-5, aryl C), 132.8 (C-4, aryl C), 136.1 
(C-6, aryl C), 163.0 (C-2, aryl C). PAB MS: m/z 349 
(dication - H+). Calcd. for C 19H34Cl2N202Si: C, 
54.14; H, 8.13; Cl, 16.82; N, 6.65. Pound: C, 54.5; 
H, 8.3; Cl, 16.6; N, 6.6%. 
RESULTS AND DISCUSSION 
The synthesis of o-methoxy-sila-hexocyclium methyi 
sulfate ( 4) is based on the approach developed for the 
preparation of the parent compound sila-hexocyclium 
methyl sulfate (lb) (see Ref. 1). Starting from readily 
available cyclohexyldimethoxy[ ( 1-methylpiperazin-
4-yl)methyl]silane1 (2), 4 was prepared by a three-
step synthesis with an overall yield of 44%. In the first 
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step, the o-methoxypheny I group was introduced by 
reaction of 2 with o-methoxyphenyllithium in diethyl 
ether to give the corresponding arylsilane 3 (yield 
68% ). Reaction of 3 with one equivalent of dimethyl 
sulfatein acetone at 20°C resulted in a selective quater-
nization of the nitrogen atom of the nitrogen-methyl 
(N-CH3) group. Because of crystallization problems, 
the respective ammoniumderivative (characterized by 
1H NMR, 13C NMR and FAB MS; data not given) 
could not be isolated as an analytically pure compound. 
Thus, after separation from the solvent and washing 
with diethyl ether, the quaternary product was 
hydrolyzed directly, without further purification, to 
give the silanol 4, which was obtained (after 
recrystallization from acetone/diethyl ether) in the form 
of analytically pure crystals (yield 64%, based on 3). 
Hydrolysis of the methoxysilane 3 yielded the cor-
responding silanol which was not isolated and purified 
but converted directly into the dihydrochloride 5. After 
recrystallization from acetonitrile, 5 was obtained as 
an analytically pure compound (yield 77%, based on 
3). 
In the solid state, the silanals 4 and 5 are stable com-
pounds which can be stored in closed flasks at room 
temperature without decomposition. In contrast, by 
analogy with other structurally related silanols, 4 and 
5 can undergo a condensation reaction in solution to 
give the corresponding disiloxanes. However, the 
o-Methoxy-sila-hexocyclium methyl sulfate 
stability in diluted aqueous solution at room 
temperature was found to be sufficient to carry out the 
phannacological experiments without special stability-
related precautions. 
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